Premium
Treatment of respiratory allergy with allergy immunotherapy tablets
Author(s) -
Bachert C.
Publication year - 2011
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.2011.02642.x
Subject(s) - respiratory allergy , allergy , medicine , respiratory system , immunotherapy , dermatology , asthma , immunology , allergen , immune system
To cite this article: Bachert C. Treatment of respiratory allergy with allergy immunotherapy tablets. Allergy 2011; 66 (Suppl. 95): 57–59. Abstract Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease‐modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.